Automated and simplified two Dimensional LC and High-Resolution MS approach for the identification and characterization of unknown impurity in Mirabegron tablets

2D-LC as an Automated Desalting Tool for MSD Analysis Direct Mass Selective Detection of a Pharmaceutical Peptide from an MS-Incompatible USP Method Application Note Biologics and Biosimilars Author Abstract Sonja Krieger The characterization and impurity analysis of therapeutic peptides and…

Screening and Identification of Potential Genotoxic Degradation Impurities using Q-TOF LC/MS with Advanced Software Solutions Application Note Pharmaceuticals Authors Abstract Siji Joseph, This Application Note demonstrates Agilent capabilities to screen, identify, and Syed Salman Lateef, Vinayak A.K, and isolate potential…

Application Note Biopharma Analysis of PROTAC Molecule Bavdegalutamide (ARV-110) Using LC/UV and LC/MS Linker E3 Ligase binding moiety Ligand binding moiety Bavdegalutamide (ARV-110) Agilent Revident LC/Q-TOF Author Abstract Suresh Babu C. V. Agilent Technologies, Inc. PROteolysis TArgeting Chimeras (PROTAC) are…

Identification and Structural Elucidation of Amlodipine Impurities Using High Resolution LC/MS and LC-MS/MS Application Note Pharmaceutical Authors Abstract Dinesh Udawant Characterization of impurities in drug products is an essential requirement in Anant Pharmaceuticals, the pharmaceutical development process. The identification of…